Word

AYRESVIQ

Status

Dead

Status Code

606

Status Date

Monday, May 22, 2023

Serial Number

97076945

Mark Type

4000

Filing Date

Friday, October 15, 2021

Published for Opposition

Tuesday, August 23, 2022

Abandoned Date

Monday, May 22, 2023

Trademark Owner History

GlaxoSmithKline Biologicals SA - Owner At Publication

Classifications

5 (Based on Intent to Use) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

May 22, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

May 22, 2023

Abandonment - No Use Statement Filed

Oct 18, 2022

Noa E-Mailed - Sou Required From Applicant

Aug 23, 2022

Official Gazette Publication Confirmation E-Mailed

Aug 23, 2022

Published For Opposition

Aug 3, 2022

Notification Of Notice Of Publication E-Mailed

Aug 2, 2022

Teas Change Of Correspondence Received

Aug 2, 2022

Teas Change Of Domestic Representatives Address

Aug 2, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 2, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 20, 2022

Electronic Record Review Complete

Jul 15, 2022

On Hold - Electronic Record Review Required

Jul 8, 2022

Approved For Pub - Principal Register

Jun 29, 2022

Assigned To Examiner

Nov 4, 2021

New Application Office Supplied Data Entered

Oct 19, 2021

New Application Entered